The Nature of the Antigen Determines Leukemia Development and Behavior in the E mu-TCL1 Transgenic Mouse Model of CLL by Bennardo, S, Iacovelli, S, Gobessi, S, Suljagic, M, Bilbao, D, Eckl-Dorna, J, Wang, H, Cornall, R, Clarke, S, Croce, C, Efremov, D

Loss of FHIT function in lung cancer and preinvasive bronchial lesions. by Sozzi, G, Pastorino, U, Moiraghi, L, Tagliabue, E, Pezzella, F, Ghirelli, C, Tornielli, S, Sard, L, Huebner, K, Pierotti, M, Croce, C, Pilotti, S

Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. by Sozzi, G, Tornielli, S, Tagliabue, E, Sard, L, Pezzella, F, Pastorino, U, Minoletti, F, Pilotti, S, Ratcliffe, C, Veronese, M, Goldstraw, P, Huebner, K, Croce, C, Pierotti, M

Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. by Iacovelli, S, Hug, E, Bennardo, S, Duehren-von Minden, M, Gobessi, S, Rinaldi, A, Suljagic, M, Bilbao, D, Bolasco, G, Eckl-Dorna, J, Niederberger, V, Autore, F, Sica, S, Laurenti, L, Wang, H, Cornall, R, Clarke, S, Croce, C, Bertoni, F, Jumaa, H, Efremov, D